LIBENTECH
Libentech develops anti-cancer viruses through the oncolytic effect of LVP-K. The company is growing into a bio-specialized company by securing various new drug R&D pipelines.
LIBENTECH
Industry:
Biotechnology Health Care Health Diagnostics Medical Device
Founded:
2020-01-01
Website Url:
http://www.libentech.kr
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Apache Mobile Non Scaleable Content Smileserv IDC
Similar Organizations
Harbr
Harbr is an accelerator and venture builder for health technology businesses.
iCareTech Healthcare
iCareTech Healthcare develops technology solutions and wearable devices that focuses on the healthcare industry.
Medivalve
MediValve is developing a new, innovative medical device intended to facilitate the accurate placement and alignment of medical devices
Official Site Inspections
http://www.libentech.kr
- Host name: 49.247.14.38
- IP address: 49.247.14.38
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Libentech"
Libentech - Crunchbase Company Profile & Funding
Organization. Libentech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Private; libentech.kr/ 1,070,778; Highlights. Investors โฆSee details»
Libentech Company Profile 2024: Valuation, Funding & Investors
Libentech General Information Description. Operator of a biotechnology platform intended to research and develop bio drugs. The company's platform develops cell lines and virus lines, โฆSee details»
Libentech - Products, Competitors, Financials, Employees, โฆ
Libentech is a company focused on the development and research of bio-pharmaceuticals within the biotechnology sector. The company offers services such as bio-pharmaceutical โฆSee details»
Libentech CO LTD - Drug pipelines, Patents, Clinical trials - Synapse
Explore Libentech CO LTD with its drug pipeline, therapeutic area, technology platform, 8 literature, Disease Domain:Neoplasms, Nervous System Diseases, Technology ...See details»
Libentech - Company Profile - Tracxn
Libentech - Provider of biopharmaceutical product development services. Raised funding from 1 investor. Libentech has 2766 competitors.See details»
Libentech - Funding, Financials, Valuation & Investors - Crunchbase
Feb 1, 2020 Libentech develops anti-cancer viruses through the oncolytic effect of LVP-K. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. โฆSee details»
์คํํธ์ DB ๋ฆฌ๋ฒคํ | ํ๊ตญ๊ฒฝ์ - ํ๊ฒฝ๋ท์ปด
์คํํธ์ DB ๋ฆฌ๋ฒคํ , ํ๊ฒฝ ๊ธฑ์ค๋ ํ์ ์ ๋ชฐ์ ํ๊ณ ๋ฏธ๋๋ฅผ ๋ฐ๊พธ๋ ๋ค์ํ ๊ธฑ(๊ดด์ง)๋ค์ ์ด์ผ๊ธฐ๋ฅผ ๋ค๋ฃน๋๋ค.See details»
Libentech - Crunchbase
Libentech develops anti-cancer viruses through the oncolytic effect of LVP-K.See details»
LIBENTECH CO., LTD. | TREA
Explore innovation relationships and map ideas to the unified knowledge graphSee details»
Libentech - 2120 Competitors and alternatives in Sep 2024 - Tracxn
Sep 19, 2024 Libentech competitors and alternatives. Provider of biopharmaceutical product development services. 2020 โข Yuseong District (South Korea) โข Funding Raised โข Yuseong โฆSee details»
Libentech Co. Ltd. - BioCentury Company Profiles - BCIQ
Libentech Co. Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
Libentech - Raised Funding from 1 investor - Tracxn
Sep 19, 2024 Libentech has raised funding from 1 investor. Investor includes Kingsley Ventures.See details»
Hyun Jang๋ - ๋ํ์ด์ฌ(President) - ๋ฆฌ๋ฒคํ ์ฃผ์ํ์ฌ (LIBENTECH)
๋ฆฌ๋ฒคํ ์ฃผ์ํ์ฌ ๋ํ์ด์ฌ President of LIBENTECH Co. LTD. · I have been 25 years working for Vaccine research and develpment area <br>especially I am interresting production process โฆSee details»
Libentech Stock Price, Funding, Valuation, Revenue ... - CB Insights
See Libentech funding rounds, investors, investments, exits and more. Evaluate their financials based on Libentech's post-money valuation and revenue. Libentech Stock Price, Funding, โฆSee details»
LVP-KT1 - Drug Targets, Indications, Patents - Synapse
LVP-KT1, Initially developed by Libentech CO LTD, Now, its global highest R&D status is Preclinical, Therapeutic Areas: Neoplasms,Digestive System Disorders, Active Indication: โฆSee details»
Pre Seed Round - Libentech - 2020-02-01 - Crunchbase
Organization Name . Libentech . Announced Date Feb 1, 2020; Funding Type Pre-Seed; Funding Stage ...See details»
Libentech - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Libentech is actively using 6 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible , Viewport Meta , and SPF . Website Tech Stack by BuiltWithSee details»
Patents Assigned to LIBENTECH CO., LTD ... - Justia Patents Search
Assignee: LIBENTECH CO., LTD. Inventors: Hyun Jang, Bo-Kyoung Jung, Yong-Hee An Ask a Lawyer. Question: Add details. 120. Additional Details: 1000 Ask Question Webinars For All โฆSee details»
LVP-KP1 - Drug Targets, Indications, Patents - Synapse
LVP-KP1, Initially developed by Libentech CO LTD, Now, its global highest R&D status is Preclinical, Therapeutic Areas: Neoplasms,Nervous System Diseases,Other Diseases, Active โฆSee details»
WO2022203117 - Drug Targets, Indications, Patents - Synapse
WO2022203117, Initially developed by Libentech CO LTD, Now, its global highest R&D status is Discovery, Therapeutic Areas: Neoplasms,Nervous System Diseases, Active Indication: โฆSee details»